Results 151 to 160 of about 43,902 (289)

Effect of denosumab on the incidence of fractures and mortality in patients undergoing hemodialysis: A retrospective cohort study.

open access: yesPLoS ONE
BackgroundPatients undergoing hemodialysis are at an elevated risk of fractures; however, substantial evidence for osteoporosis treatment in this population is lacking.
Arisa Kobayashi   +5 more
doaj   +1 more source

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid [PDF]

open access: bronze, 2014
Roger von Moos   +13 more
openalex   +1 more source

Advances in Molecularly Imprinted Polymers for Bone Biomarker Detection and Therapeutic Applications

open access: yesChemistryOpen, Volume 14, Issue 11, November 2025.
This review highlights the emerging applications of molecularly imprinted polymers (MIPs) in bone regeneration and diagnosis. MIPs facilitate osteogenic treatments by guiding stem cell differentiation and delivering bioactive molecules and enable precise detection of bone turnover biomarkers via MIP‐based sensors, offering promising strategies for next‐
Ren Yang   +8 more
wiley   +1 more source

Denosumab-induced severe hypocalcemia in a patient with Crohn's disease [PDF]

open access: yes, 2014
Osteoporosis occurs with increased prevalence in individuals with inflammatory bowel disease (IBD), and as such, these patients are at risk for osteoporosis-related fractures.
Katta, Natraj   +3 more
core  

Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway

open access: yesPhytotherapy Research, Volume 39, Issue 11, Page 4977-4990, November 2025.
ABSTRACT Osteoporosis, characterized by osteoclastic bone resorption, has been the focus of research. Studies implicate that reactive oxygen species (ROS) accumulate intracellularly during osteoclastogenesis. Salvianolic acid A (SAA), a compound derived from Salvia miltiorrhiza, has been widely used to treat cardiovascular and cerebrovascular disorders,
Hao Qiu   +5 more
wiley   +1 more source

A rare case of sphenoid giant cell tumor: Case report & review of imaging features post short-term denosumab treatment

open access: gold, 2022
Farid Aassouani   +11 more
openalex   +1 more source

The Use of Etanercept in the Palliative Treatment of a Patient With Generalised Bullous Fixed Drug Eruption

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 7, Page e471-e473, November 2025.
ABSTRACT Generalised Bullous Fixed Drug Eruption (GBFDE) is a subtype of Fixed Drug Eruption (FDE) characterised by the development of generalised blisters on the background of dusky macules. There is no gold standard treatment, but the condition is conventionally managed with supportive care, topical and oral steroids and occasionally ciclosporin.
Olga Pawlik   +2 more
wiley   +1 more source

Prognostic Value and Quantitative CT Analysis in RANKL Expression of Spinal GCTB in the Denosumab Era: A Machine Learning Approach [PDF]

open access: gold, 2022
Qizheng Wang   +8 more
openalex   +1 more source

Effect of Depletion of Developmentally Regulated GTP Binding Protein on Osteoblastic Differentiation and Bone Microarchitecture

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.
ABSTRACT Previous studies have demonstrated that overexpression of DRG2 enhances the osteoclastic activity. However, its impact on osteoblastic differentiation remains unexplored. This study investigates the relationship between DRG2 and osteoblastic activity through in vitro and in vivo studies.
Yuan‐Zhe Jin   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy